COLUMBIA, S.C.--(BUSINESS WIRE)--ClearPoint Health (“ClearPoint”) is a medical stop-loss captive platform for small and mid-sized employers. ClearPoint’s platform empowers employers and benefit ...

Clearpoint Agency has once again been recognized for excellence in public relations. The firm was awarded a 2025 Edward L. Bernays Bronze Merit Award from the Public Relations Society of America (PRSA ...

Earnings call ClearPoint Neuro reported Q3 2025 revenue of $8.9M, up 9% YoY, with gross margin expanding to 63%. Management reaffirmed FY25 revenue guidance of $36M–$38M and issued preliminary 2026 ...

ClearPoint Neuro's progress on its four-pillar strategy continues despite a challenging operating environment, with an increasing number of partners and hospital sites featuring its equipment. The ...

COLUMBIA, SC, UNITED STATES, March 26, 2025 / EINPresswire.com / -- ClearPoint Health invites benefit advisors, human resources professionals, and employers to a free webinar event celebrating the ...

ClearPoint Health (“ClearPoint”) is a medical stop-loss captive platform for small and mid-sized employers. ClearPoint’s platform empowers employers and benefit advisors to transition employee health ...

ClearPoint Neuro CLPT recently unveiled the development of its proprietary Robotic Neuro-Navigation System, a move that positions the company to contribute to robotics, neurosurgery, and advanced drug ...

Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire ...

Both NeuroOne and ClearPoint Neuro are emerging as significant players in the neurological device sector, each carving out their own niche, with ClearPoint focusing on drug delivery and NeuroOne ...

ClearPoint Neuro (NASDAQ:CLPT) reported its Q3 2025 financial results on November 6, revealing a mixed performance. The company posted a revenue of $8.9 million, falling short of the $9.8 million ...